Serum reactivity to citrullinated proteins/peptides in a community-living population is unclear, although prior studies have reported a 1% ACPA prevalence in study populations of RA-free individuals in Turkey and Japan [22, 23]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.